Dysmenorrhea in Adolescents
Dysmenorrhea is the most common gynecologic complaint among adolescent females. Dysmenorrhea in adolescents is usually primary, and is associated with normal ovulatory cycles and with no pelvic pathology. In approximately 10% of adolescents with severe dysmenorrheic symptoms, pelvic abnormalities su...
Gespeichert in:
Veröffentlicht in: | Annals of the New York Academy of Sciences 2008-06, Vol.1135 (1), p.185-195 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 195 |
---|---|
container_issue | 1 |
container_start_page | 185 |
container_title | Annals of the New York Academy of Sciences |
container_volume | 1135 |
creator | Harel, Zeev |
description | Dysmenorrhea is the most common gynecologic complaint among adolescent females. Dysmenorrhea in adolescents is usually primary, and is associated with normal ovulatory cycles and with no pelvic pathology. In approximately 10% of adolescents with severe dysmenorrheic symptoms, pelvic abnormalities such as endometriosis or uterine anomalies may be found. Potent prostaglandins and leukotrienes play an important role in generating the symptoms of dysmenorrhea. Nonsteroidal anti‐inflammatory drugs (NSAIDs) are the most common pharmacologic treatment for dysmenorrhea. A loading dose of NSAIDs (typically twice the regular dose) should be used as initial treatment for dysmenorrhea in adolescents, followed by a regular dose until symptoms abate. Adolescents with symptoms that do not respond to treatment with NSAIDs for three menstrual periods should be offered hormonal treatment such as combined estrogen/progestin oral contraceptive pills for three menstrual cycles. Adolescents with dysmenorrhea who do not respond to this treatment should be evaluated for secondary causes of dysmenorrhea. The adolescent care provider's role is to explain the pathophysiology of dysmenorrhea to every adolescent female, address any concern that the patient has about her menstrual period, and review effective treatment options for dysmenorrhea with the patient. |
doi_str_mv | 10.1196/annals.1429.007 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69239961</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69239961</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4737-cfa385e767b7f3182b381d921ad8db2c27fb0e044ea83833dd0056e09144c3433</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMotlbPHgTpydu2mSSbj2OpWoVakdaKp5DdzeLqftSkRfvvTdmiR08Dw_M-zLwInQMeACg-NHVtSj8ARtQAY3GAuiCYijin5BB1w0ZEUhHaQSfev2MMRDJxjDogY8EIYV10cb31la0b596s6Rd1f5Q1pfWprdf-FB3lwW7P9rOHnm9vFuO7aPo4uR-PplHKBBVRmhsqYyu4SEROQZKESsgUAZPJLCEpEXmCLWbMGkklpVmGccwtVsBYShmlPXTVeleu-dxYv9ZVES4oS1PbZuM1Dx8oxSGAwxZMXeO9s7leuaIybqsB610fuu1D7_rQ4fuQuNyrN0llsz9-X0AAZAt8FaXd_ufTs9fRHIDGrTtqo4Vf2-_fqHEfmodeYv0ym2i2nD4s5vCkl_QHgVN7gA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69239961</pqid></control><display><type>article</type><title>Dysmenorrhea in Adolescents</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Harel, Zeev</creator><creatorcontrib>Harel, Zeev</creatorcontrib><description>Dysmenorrhea is the most common gynecologic complaint among adolescent females. Dysmenorrhea in adolescents is usually primary, and is associated with normal ovulatory cycles and with no pelvic pathology. In approximately 10% of adolescents with severe dysmenorrheic symptoms, pelvic abnormalities such as endometriosis or uterine anomalies may be found. Potent prostaglandins and leukotrienes play an important role in generating the symptoms of dysmenorrhea. Nonsteroidal anti‐inflammatory drugs (NSAIDs) are the most common pharmacologic treatment for dysmenorrhea. A loading dose of NSAIDs (typically twice the regular dose) should be used as initial treatment for dysmenorrhea in adolescents, followed by a regular dose until symptoms abate. Adolescents with symptoms that do not respond to treatment with NSAIDs for three menstrual periods should be offered hormonal treatment such as combined estrogen/progestin oral contraceptive pills for three menstrual cycles. Adolescents with dysmenorrhea who do not respond to this treatment should be evaluated for secondary causes of dysmenorrhea. The adolescent care provider's role is to explain the pathophysiology of dysmenorrhea to every adolescent female, address any concern that the patient has about her menstrual period, and review effective treatment options for dysmenorrhea with the patient.</description><identifier>ISSN: 0077-8923</identifier><identifier>EISSN: 1749-6632</identifier><identifier>DOI: 10.1196/annals.1429.007</identifier><identifier>PMID: 18574224</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Adolescent ; adolescents ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Contraceptives, Oral, Combined - therapeutic use ; Contraceptives, Oral, Hormonal - therapeutic use ; dysmenorrhea ; Dysmenorrhea - diagnosis ; Dysmenorrhea - epidemiology ; Dysmenorrhea - etiology ; Dysmenorrhea - physiopathology ; Dysmenorrhea - therapy ; Estrogens - therapeutic use ; Female ; Humans ; Menstrual Cycle - physiology ; Prevalence ; Progesterone Congeners - therapeutic use ; Risk Factors ; secondary dysmenorrhea</subject><ispartof>Annals of the New York Academy of Sciences, 2008-06, Vol.1135 (1), p.185-195</ispartof><rights>2008 New York Academy of Sciences</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4737-cfa385e767b7f3182b381d921ad8db2c27fb0e044ea83833dd0056e09144c3433</citedby><cites>FETCH-LOGICAL-c4737-cfa385e767b7f3182b381d921ad8db2c27fb0e044ea83833dd0056e09144c3433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1196%2Fannals.1429.007$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1196%2Fannals.1429.007$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18574224$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Harel, Zeev</creatorcontrib><title>Dysmenorrhea in Adolescents</title><title>Annals of the New York Academy of Sciences</title><addtitle>Ann N Y Acad Sci</addtitle><description>Dysmenorrhea is the most common gynecologic complaint among adolescent females. Dysmenorrhea in adolescents is usually primary, and is associated with normal ovulatory cycles and with no pelvic pathology. In approximately 10% of adolescents with severe dysmenorrheic symptoms, pelvic abnormalities such as endometriosis or uterine anomalies may be found. Potent prostaglandins and leukotrienes play an important role in generating the symptoms of dysmenorrhea. Nonsteroidal anti‐inflammatory drugs (NSAIDs) are the most common pharmacologic treatment for dysmenorrhea. A loading dose of NSAIDs (typically twice the regular dose) should be used as initial treatment for dysmenorrhea in adolescents, followed by a regular dose until symptoms abate. Adolescents with symptoms that do not respond to treatment with NSAIDs for three menstrual periods should be offered hormonal treatment such as combined estrogen/progestin oral contraceptive pills for three menstrual cycles. Adolescents with dysmenorrhea who do not respond to this treatment should be evaluated for secondary causes of dysmenorrhea. The adolescent care provider's role is to explain the pathophysiology of dysmenorrhea to every adolescent female, address any concern that the patient has about her menstrual period, and review effective treatment options for dysmenorrhea with the patient.</description><subject>Adolescent</subject><subject>adolescents</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Contraceptives, Oral, Combined - therapeutic use</subject><subject>Contraceptives, Oral, Hormonal - therapeutic use</subject><subject>dysmenorrhea</subject><subject>Dysmenorrhea - diagnosis</subject><subject>Dysmenorrhea - epidemiology</subject><subject>Dysmenorrhea - etiology</subject><subject>Dysmenorrhea - physiopathology</subject><subject>Dysmenorrhea - therapy</subject><subject>Estrogens - therapeutic use</subject><subject>Female</subject><subject>Humans</subject><subject>Menstrual Cycle - physiology</subject><subject>Prevalence</subject><subject>Progesterone Congeners - therapeutic use</subject><subject>Risk Factors</subject><subject>secondary dysmenorrhea</subject><issn>0077-8923</issn><issn>1749-6632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhoMotlbPHgTpydu2mSSbj2OpWoVakdaKp5DdzeLqftSkRfvvTdmiR08Dw_M-zLwInQMeACg-NHVtSj8ARtQAY3GAuiCYijin5BB1w0ZEUhHaQSfev2MMRDJxjDogY8EIYV10cb31la0b596s6Rd1f5Q1pfWprdf-FB3lwW7P9rOHnm9vFuO7aPo4uR-PplHKBBVRmhsqYyu4SEROQZKESsgUAZPJLCEpEXmCLWbMGkklpVmGccwtVsBYShmlPXTVeleu-dxYv9ZVES4oS1PbZuM1Dx8oxSGAwxZMXeO9s7leuaIybqsB610fuu1D7_rQ4fuQuNyrN0llsz9-X0AAZAt8FaXd_ufTs9fRHIDGrTtqo4Vf2-_fqHEfmodeYv0ym2i2nD4s5vCkl_QHgVN7gA</recordid><startdate>200806</startdate><enddate>200806</enddate><creator>Harel, Zeev</creator><general>Blackwell Publishing Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200806</creationdate><title>Dysmenorrhea in Adolescents</title><author>Harel, Zeev</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4737-cfa385e767b7f3182b381d921ad8db2c27fb0e044ea83833dd0056e09144c3433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Adolescent</topic><topic>adolescents</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Contraceptives, Oral, Combined - therapeutic use</topic><topic>Contraceptives, Oral, Hormonal - therapeutic use</topic><topic>dysmenorrhea</topic><topic>Dysmenorrhea - diagnosis</topic><topic>Dysmenorrhea - epidemiology</topic><topic>Dysmenorrhea - etiology</topic><topic>Dysmenorrhea - physiopathology</topic><topic>Dysmenorrhea - therapy</topic><topic>Estrogens - therapeutic use</topic><topic>Female</topic><topic>Humans</topic><topic>Menstrual Cycle - physiology</topic><topic>Prevalence</topic><topic>Progesterone Congeners - therapeutic use</topic><topic>Risk Factors</topic><topic>secondary dysmenorrhea</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Harel, Zeev</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of the New York Academy of Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Harel, Zeev</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dysmenorrhea in Adolescents</atitle><jtitle>Annals of the New York Academy of Sciences</jtitle><addtitle>Ann N Y Acad Sci</addtitle><date>2008-06</date><risdate>2008</risdate><volume>1135</volume><issue>1</issue><spage>185</spage><epage>195</epage><pages>185-195</pages><issn>0077-8923</issn><eissn>1749-6632</eissn><abstract>Dysmenorrhea is the most common gynecologic complaint among adolescent females. Dysmenorrhea in adolescents is usually primary, and is associated with normal ovulatory cycles and with no pelvic pathology. In approximately 10% of adolescents with severe dysmenorrheic symptoms, pelvic abnormalities such as endometriosis or uterine anomalies may be found. Potent prostaglandins and leukotrienes play an important role in generating the symptoms of dysmenorrhea. Nonsteroidal anti‐inflammatory drugs (NSAIDs) are the most common pharmacologic treatment for dysmenorrhea. A loading dose of NSAIDs (typically twice the regular dose) should be used as initial treatment for dysmenorrhea in adolescents, followed by a regular dose until symptoms abate. Adolescents with symptoms that do not respond to treatment with NSAIDs for three menstrual periods should be offered hormonal treatment such as combined estrogen/progestin oral contraceptive pills for three menstrual cycles. Adolescents with dysmenorrhea who do not respond to this treatment should be evaluated for secondary causes of dysmenorrhea. The adolescent care provider's role is to explain the pathophysiology of dysmenorrhea to every adolescent female, address any concern that the patient has about her menstrual period, and review effective treatment options for dysmenorrhea with the patient.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>18574224</pmid><doi>10.1196/annals.1429.007</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0077-8923 |
ispartof | Annals of the New York Academy of Sciences, 2008-06, Vol.1135 (1), p.185-195 |
issn | 0077-8923 1749-6632 |
language | eng |
recordid | cdi_proquest_miscellaneous_69239961 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Adolescent adolescents Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Contraceptives, Oral, Combined - therapeutic use Contraceptives, Oral, Hormonal - therapeutic use dysmenorrhea Dysmenorrhea - diagnosis Dysmenorrhea - epidemiology Dysmenorrhea - etiology Dysmenorrhea - physiopathology Dysmenorrhea - therapy Estrogens - therapeutic use Female Humans Menstrual Cycle - physiology Prevalence Progesterone Congeners - therapeutic use Risk Factors secondary dysmenorrhea |
title | Dysmenorrhea in Adolescents |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T13%3A27%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dysmenorrhea%20in%20Adolescents&rft.jtitle=Annals%20of%20the%20New%20York%20Academy%20of%20Sciences&rft.au=Harel,%20Zeev&rft.date=2008-06&rft.volume=1135&rft.issue=1&rft.spage=185&rft.epage=195&rft.pages=185-195&rft.issn=0077-8923&rft.eissn=1749-6632&rft_id=info:doi/10.1196/annals.1429.007&rft_dat=%3Cproquest_cross%3E69239961%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69239961&rft_id=info:pmid/18574224&rfr_iscdi=true |